Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million

Sep.17.2025
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Technology Inc. (NASDAQ: ISPR) announced its financial results for the fiscal year ending June 30, 2025, on September 16, 2025. The report showed that the company's operating revenue was $127.5 million, down from $151.9 million in the previous fiscal year. Gross profit decreased from $29.8 million to $22.6 million, with gross profit margin falling from 19.6% to 17.8%. Net loss widened from $14.8 million to $39.2 million.

Key points:

 

·Income Decline: In the 2025 fiscal year, Ispire Technology's operating income was $127.5 million, a 16.1% decrease from the $151.9 million in the 2024 fiscal year. 

·Gross profit and gross margin decrease: Gross profit decreased from $29.8 million to $22.6 million, with the gross margin decreasing from 19.6% to 17.8%. 

·Net loss expands: The net loss expanded from $14.8 million to $39.2 million. 

·Strategic transformation: The company continues to transition from the cannabis industry to the nicotine sector.

 


 

On September 17, 2025 - According to a report on the Ispire Technology website on September 16, Ispire Technology Inc. (NASDAQ: ISPR) announced its fiscal year financial report for the period ending on June 30, 2025. The report showed that the company's revenue for the 2025 fiscal year was $127.5 million, a decrease from $151.9 million in the previous fiscal year. Gross profit decreased from $29.8 million in the previous fiscal year to $22.6 million, with a gross profit margin dropping from 19.6% to 17.8%. Net losses widened from $14.8 million in the previous fiscal year to $39.2 million. As of June 30, 2025, the company held cash and cash equivalents of $24.4 million, with operating capital of $400,000.

 

In the 2025 fiscal year, Ispire's revenue was $127.5 million, a decrease from $151.9 million in the 2024 fiscal year. This decline is primarily due to the company's strategic repositioning from the cannabis sector to the nicotine sector, despite the aim of achieving more sustainable long-term growth through this transition. Gross profit decreased from $29.8 million in the previous fiscal year to $22.6 million, with a gross margin drop from 19.6% to 17.8%. Total operating expenses increased from $43.7 million in 2024 to $60.5 million, mainly due to higher sales and marketing expenses and an increase in expected credit losses on accounts receivable.

 

The net loss expanded from $14.8 million in the 2024 fiscal year to $39.2 million in the 2025 fiscal year. This increase in loss reflects the challenges the company is facing during its strategic transformation, including increased operational expenses and declining revenues. As of June 30, 2025, the company held $24.4 million in cash and cash equivalents, with operating capital of $400,000.

 

Ispire Co-CEO Michael Wang said, "The 2025 fiscal year is a crucial period for Ispire's strategic transformation as we continue to shift our focus from the cannabis industry to the higher value nicotine industry. We have made sound strategic decisions, prioritizing quality customers over quantity, and repositioning our business for sustainable growth while prioritizing long-term partnerships. Our investments in groundbreaking technologies, including IKE Tech LLC and G-Mesh technology, are gaining favor with major tobacco companies as these innovative technologies go through regulatory approval processes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Africa health department agrees to exempt smokeless and non-combustible products from tobacco control bill
South Africa health department agrees to exempt smokeless and non-combustible products from tobacco control bill
At a parliamentary committee meeting in South Africa, Health Minister Aaron Motsoaledi said the health department has agreed to exempt non-combustible and smokeless products — including chewing tobacco, snus, nicotine pouches and e-cigarettes — from the Tobacco Products and Electronic Delivery Systems Control Bill. The department is prepared, at this stage, to exempt them from packaging and labelling requirements except for misleading or false claims.
Mar.06 by 2FIRSTS.ai
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Uwell has recently launched its new disposable vape, the VALAYA AMP 60K, on its official website. The device features 20ml of pre-filled e-liquid and is rated for up to approximately 60,000 puffs. It is equipped with a 950mAh rechargeable battery and a 0.6Ω dual mesh coil. The product is now available through select online channels in the United States, with a listed price of $19.99.
Apr.09 by 2FIRSTS.ai
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French anti-tobacco group Contre-Feu said in a statement released on April 14 that e-cigarette manufacturers are encouraging nicotine dependence among young people through targeted marketing and called for concrete measures to protect minors. The group asked for plain packaging for all vaping products, strict regulation of flavor names, and a ban on online sales.
Apr.15 by 2FIRSTS.ai
Netherlands Plans Law to Ban Possession of Large Quantities of Vapes Intended for Trade
Netherlands Plans Law to Ban Possession of Large Quantities of Vapes Intended for Trade
Dutch Health Minister Hermans is drafting legislation that would also ban possession of larger quantities of vapes, allowing the Netherlands Food and Consumer Product Safety Authority to intervene earlier and seize stock before proving that trade has taken place.
Apr.13 by 2FIRSTS.ai
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Shenzhen tobacco authorities have asked licensed Chinese vape manufacturers to submit STN details for U.S.-bound products, including CTP Portal or STN email screenshots, highlighting a new compliance signal in cross-border oversight.
Apr.02
Italy Formally Submits Detailed Opinion to EU Obstructing Ireland's Disposable Vape Ban
Italy Formally Submits Detailed Opinion to EU Obstructing Ireland's Disposable Vape Ban
Italy's Ministry of Enterprises and Made in Italy has submitted a detailed opinion against Ireland's proposed "Public Health (Single Use Vapes) Bill 2025." Italy argued that the comprehensive ban on disposable vapes lacks scientific evidence, violates the EU principle of the free movement of goods, and conflicts with the existing Tobacco Products Directive.
Apr.10 by 2FIRSTS.ai